Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review
InfectologiaResumo original em inglês
O que aconteceu
To evaluate the susceptibility and resistance of Aspergillus and Mucorales isolates to antifungal agents.
Studies in susceptibility or resistance of Aspergillus and Mucorales isolates to antifungal agents published between January 2010 and June 2023 were systematically searched in PubMed, EMBASE and the Cochrane Library. The minimum inhibitory concentration (MIC), susceptibility and resistance data were analysed using CLSI or EUCAST methods.
O que encontraram
After following the systematic review processes, 96 studies were included. The total number of isolates was 16,258. Compared with existing MIC distributions and breakpoints or epidemiological cutoff values (ECVs) established by CLSI or EUCAST, for A. flavus, the posaconazole and voriconazole MIC values were at or below the ECV, indicating that the isolates were wild-type (WT) strains; however, the amphotericin B, isavuconazole and itraconazole MIC values were elevated. For A. fumigatus, the isavuconazole MIC values were within ECV limits, indicating that the isolates were WT strains; however, the amphotericin B, posaconazole and voriconazole MIC values were elevated. For A. niger, the isavuconazole and voriconazole MIC values were within ECV limits, indicating that the isolates were WT strains; however, the amphotericin B and posaconazole MIC values were elevated. A. flavus had consistently high in vitro susceptibility to voriconazole, and A. fumigatus and A. niger had consistently high in vitro susceptibility to amphotericin B. For Mucorales, the resistance to amphotericin B was consistently at the lowest level. The subgroup analysis indicated that the resistance among the strains in the environment was higher than that of the clinical isolates.
Por que isso importa
Trends in susceptibility and resistance of Aspergillus and Mucorales isolates should be adequately considered in antifungal therapy. The evaluation of drug resistance is beneficial in that it enables clinicians to choose suitable drugs and appropriate doses.
Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.
O estudo original
Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review
Yinggai Song, Paul E Verweij, Jochem B Buil, Sybren de Hoog, Jie Liu, Jiaxian Guo, Wei Liu, Ruoyu Li
Descritores MeSH
- Mucorales
- Mucormycosis
- Aspergillus
- Drug Resistance, Fungal
- Antifungal Agents
- Aspergillosis
- Voriconazole
- Humans
- Microbial Sensitivity Tests
- Triazoles
Veja também
Estudos relacionados
- Aspergillus spp. osteoarticular infections: an updated systematic review on the diagnosis, treatment and outcomes of 186 confirmed cases
- Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta-Analysis
- Meta-analysis of antifungal resistance patterns of Aspergillus species in Iran
- Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review